First Analysis
Edit

First Analysis

https://www.firstanalysis.com
Last activity: 30.05.2025
Active
Invests in categories: BrandCareDataEmployeeManagementPlatformProductServiceSoftwareTechnology
News
107
Portfolio
26
Persons
11
Mentions
26
Employees: 11-50
Investment Stage: Series A

Portfolio 26

DateNameWebsiteTotal RaisedLocation
11.09.2024Swaresware.com$21MUnited Sta...
11.09.2024Applied St...appliedstemcell.com$19MUnited Sta...
10.03.2024Dina Caredinacare.com$7MUnited Sta...
01.11.2023Stamus Net...stamus-networks.com$7.5MUnited Sta...
29.10.2022Drive My W...drivemyway.com$4.4MUnited Sta...
20.10.2022CoolR Grou...coolrgroup.com$10MUnited Sta...
20.10.2022Yunuyunu.io-United Sta...
17.08.2022EdgeIQedgeiq.ai$8.5MUnited Sta...
06.03.2022Insellerat...insellerate.com-United Sta...
03.12.2021Lender Pri...lenderprice.com-Philippine...
Show more

Persons 11

DateFirst NameLast NameTitleLinkedInLocation
-JamesMacdonaldManaging D...-
-JosephMundaManaging D...-
-KennyGuerreroAssociate-
-JosephineHoranStaff Acco...-
-DanielleLLevadaAdministra...-
-CoreyGreendaleManaging D...-
-NicholasCoffeyAnalyst-
-WalidElmekkiAssociate-
-MatthewNicklinManaging D...-
-HowardSmithManaging D...-
Show more

News 107

DateTitleDescription
25.04.2025First Analysis invests in Gradient Cyber, provider of MXDR services for mid-market organizations First Analysis, a leading venture capital investor, has made a new investment in Gradient Cyber, a leading provider of managed extended detection and response (MXDR) services for mid-market organizations. First Analysis led the Series A fin...
09.04.2025First Analysis closes on Fund XIV at $97 million in committed capital First Analysis, a leading venture capital firm specializing in B2B technology investments, announced today the closing of its 14th fund at $97 million in committed capital. First Analysis again committed substantial capital to its own fund,...
21.03.2025First Analysis portfolio company PCMI receives strategic growth investment from Thoma Bravo Thoma Bravo, a leading software investment firm, has made a strategic growth investment in PCMI, a portfolio company of First Analysis and Equality Asset Management. PCMI is a leading provider of administration software for finance and insu...
11.03.2025First Analysis portfolio company AmpliFund has been acquired by Euna Solutions Euna Solutions, a provider of SaaS solutions purpose-built for the public sector, has acquired First Analysis portfolio company AmpliFund, a leading grant management platform provider. This strategic move enhances Euna Solutions’ existing g...
11.02.2025First Analysis acted as the exclusive financial advisor to TBX in its sale to Selerix First Analysis acted as the exclusive financial advisor to The Benefits eXpert® (TBX), an employee benefits technology company that offers an engagement, education and administrative platform, in its sale to Selerix, a provider of cloud-bas...
07.02.2025First Analysis acted as the exclusive financial advisor to Upfront Healthcare in its sale to Health Catalyst First Analysis acted as the exclusive financial advisor to Upfront Healthcare Services (Upfront), a next-generation patient engagement platform provider, in its sale to Health Catalyst (Nasdaq: HCAT), a provider of data and analytics techno...
07.10.2024First Analysis portfolio company VisiQuate has been acquired by Accel-KKR Accel-KKR has acquired First Analysis portfolio company VisiQuate, a provider of advanced revenue cycle analytics, AI-powered workflow and automation solutions. The strategic partnership leverages Accel-KKR's extensive resources and strateg...
16.07.2024First Analysis invests in Applied StemCell, a leading cell and gene therapy CRO/CDMO First Analysis, a leading venture capital investor, has made a new investment in Applied StemCell (ASC), a contract development and manufacturing organization (CDMO) specializing in tailored cell and gene therapy solutions. First Analysis c...
07.06.2024First Analysis invests in Sware, provider of FDA-mandated computer system validation automation for GxP systems and release testing First Analysis, a leading venture capital investor, has made a new investment in Sware, which provides a complete software validation solution for innovative life sciences companies. The investment will be used to bolster research and devel...
22.03.2024First Analysis acted as the exclusive financial advisor to Pharmacy Quality Solutions in its sale to Innovaccer First Analysis acted as the exclusive financial advisor to Pharmacy Quality Solutions (PQS), a leading pharmacy-payer performance technology, in its sale to Innovaccer. The terms of the transaction were not disclosed.
Show more

Mentions in press and media 26

DateTitleDescription
09.04.2025First Analysis closes on Fund XIV at $97 million in committed capital First Analysis, a leading venture capital firm specializing in B2B technology investments, announced today the closing of its 14th fund at $97 million in committed capital. First Analysis again committed substantial capital to its own fund,...
10.09.2024CSA Medical's $53 Million Boost: A Breath of Fresh Air for Chronic Bronchitis TreatmentIn the bustling world of medical innovation, CSA Medical has just made waves. The Boston-based company recently secured $53 million in Series D funding. This investment is not just a number; it represents hope for countless patients sufferi...
09.09.2024CSA Medical Raises $53M in Series D FinancingRejuvenAir Metered Cryospray CSA Medical, a Boston, Ma-based developer of The RejuvenAir® System, a medical device advancing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis, raised $53M in Series D funding. The rou...
09.09.2024CSA Medical: $53 Million (Series D) Raised For Advancing RejuvenAir SystemCSA Medical, the developer of The RejuvenAir System (a Breakthrough Medical Device advancing the power of liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis), announced the completion of an oversubscribed $53 million ...
07.06.2024Sware Revolutionizes Software Validation for Life Sciences IndustryA deep dive into how Sware's innovative platform is reshaping the validation process for pharmaceutical, medical device, and biotechnology companies, eliminating validation debt and streamlining operations. In a world where software updates...
06.06.2024Sware, a software validation platform for the life sciences industry, raises $6MThe company automates the validation process that the FDA requires every time software is updated Every time software that pharma, medical device and biotech companies use for development and manufacturing gets updated, the FDA requires it ...
10.03.2023First Analysis acted as the exclusive financial advisor to Masttro in its $43 million growth equity investment led by FTV Capital First Analysis acted as the exclusive financial advisor to Masttro in its $43 million growth equity investment led by FTV Capital. Citi Ventures also participated. Masttro is a leading wealth technology company serving family offices, finan...
20.05.2021First Analysis acted as the exclusive financial advisor to SymphonyRM for its $25 million Series B funding led by TT Capital Partners First Analysis acted as the exclusive financial advisor to SymphonyRM for its $25 million Series B funding. SymphonyRM transforms healthcare providers into member-focused enterprises through its innovative HealthOS platform. The round was l...
19.03.2021Visage Raises $7 Million Series A Led by First Analysis to Streamline Candidate Sourcing for Large Enterprise EmployersA leading AI-powered recruiting platform combining human and artificial intelligence to rapidly and effectively source the best talent. Visage, a collaborative candidate sourcing platform, announced it has raised a $7 million Series A inves...
18.03.2021Visage : Raises $7M Series A Led by First Analysis to Streamline Candidate Sourcing for Large Enterprise EmployersSAN FRANCISCO, March 18, 2021 /PRNewswire/ -- Visage, a collaborative candidate sourcing platform, today announced it has raised a $7 million Series A investment led by First Analysis with participation from existing investors Urban Innovat...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In